Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
17,965
Total Claims
$602K
Drug Cost
549
Beneficiaries
$1,097
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-98%
Opioid rate vs peers
0.1% vs 3.8% avg
-7%
Cost per patient vs peers
$1,097 vs $1,174 avg
-4%
Brand preference vs peers
8.5% vs 8.9% avg
Opioid Prescribing
0.1%
Opioid Rate
13
Opioid Claims
$47
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,511 claims · $364K
Generic: 16,283 claims · $235K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 186 | $102K |
| Rivaroxaban | 185 | $96K |
| Insulin Glargine,hum.Rec.Anlog | 245 | $21K |
| Sacubitril/Valsartan | 27 | $17K |
| Budesonide/Formoterol Fumarate | 67 | $16K |
| Atorvastatin Calcium | 1,358 | $14K |
| Alogliptin Benzoate | 76 | $14K |
| Albuterol Sulfate | 298 | $13K |
| Sitagliptin Phosphate | 22 | $12K |
| Esomeprazole Magnesium | 207 | $11K |
| Losartan Potassium | 699 | $10K |
| Ticagrelor | 24 | $10K |
| Levothyroxine Sodium | 262 | $9,523 |
| Labetalol Hcl | 128 | $8,792 |
| Dabigatran Etexilate Mesylate | 24 | $7,992 |
Prescribing Profile
Patient Profile
76
Avg Age
64%
Female
2.28
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data